Navigation Links
Researchers to develop next generation immunotherapy for children with deadly solid tumors
Date:4/3/2013

en with neuroblastoma and is estimated to open before the end of the year. Stephan Grupp, M.D., Ph.D., Professor of Pediatrics at the Children's Hospital of Philadelphia, will direct the trial in collaboration with Michael Pulsipher, M.D., Professor of Pediatrics at the Primary Children's Medical Center/University of Utah, and Carl June, M.D., the Director of Translational Research at the Abramson Cancer Center at the University of Pennsylvania, who led the altered T-cell/HIV study.

Today, children with relapsed high-risk neuroblastoma have little or no options to cure their disease through traditional methods, including chemotherapy, surgery and radiation. Early clinical studies utilizing cancer immunotherapies such as modified T-cells have demonstrated initial success and promising potential as more effective treatment options in some blood cancers, including chronic myelogenous leukemia in adults and acute lymphoblastic leukemia in children.

"The ACT FAST initiative aims to bring the newest engineered T cell therapies to pediatric solid tumors. The ACT FAST approach is rigorous, highly focused and intensely translational. By collaborating with pediatric physician-scientists across institutions through ACT FAST, we will not only be able to advance research into engineered T-cell treatments, but just as importantly, offer cutting-edge cancer immunotherapy clinical trial options rapidly to children whose cancer recurs or resists current treatment," said Dr. Grupp.


'/>"/>

Contact: Jenny Song
jenny@solvingkidscancer.org
212-588-6625
Solving Kids' Cancer
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Safeguard Scientifics, ... the Company, from time to time and depending on market conditions, to repurchase ... $25 million. Repurchases will be made in open market or privately negotiated transactions ...
(Date:7/28/2015)... New York, NY (PRWEB) , ... July 28, ... ... specialty benefit management services to include a proprietary, web based clinical knowledge system, ... algorithms that are evidence based. It provides physicians who are anticipating making ...
(Date:7/28/2015)... GA (PRWEB) , ... July 28, 2015 , ... ... been chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual ... row by hundreds of her esteemed colleagues and peers in the metro area as ...
(Date:7/28/2015)... ... 2015 , ... A new study published by HealthDay News on June 24, ... on a possible new treatment option for people living with fibromyalgia – hyperbaric oxygen ... least five per week, patients experienced a significant decrease in pain, fatigue, and other ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom are missed ... the identification of individuals with active yet undetected sub-clinical disease, who are at ...
Breaking Medicine News(10 mins):Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2
... in the UK most people believe that asthma is a ... asthma develop the condition in adulthood and it can be ... early stages. Asthma can occur in an individual for the ... where many people don't realise they have asthma.// However, around ...
... The Diabetes Research and Wellness Foundation is predicting a 300pc ... Diabetes, though other experts say this figure is possibly a ... is indicated that an epidemic of type two diabetes is ... lead to heart disease, blindness and kidney failure. It is ...
... cells has cured mice suffering with a form of ... of their back legs, and many showed improvement. Researchers ... the brains of adult in the bloodstream or spinal ... had migrated to and then repaired damaged areas of ...
... World Health Organization said that it should take three to ... China. Since mid-February, an international team from WHO has been ... full partner with China in the investigation of SARS. China ... accounting for about half of the global total. The WHO ...
... its a common belief that asthma is a condition ... most common long-term conditions affecting people in the UK. ... that around 40% of people with asthma develop the ... are not recognised and corrected. However, around two-thirds// of ...
... expecting moms will do whatever needs to be done. ,Whether it ... moms who smoke, ready to set ,aside their habit or smokers ... habit on ,hold for the sake of the child? ,A ... County Tobacco Control Committee was ,that// Baxter County has the highest ...
Cached Medicine News:
(Date:7/28/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today its results for the ... Pat Mackin, Chairman, President and Chief Executive ... on our growth strategy with solid progress on several ... plans to transition to a direct sales model in ...
(Date:7/28/2015)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... quarter and year-to-date 2015 financial results on Tuesday, August ... markets. The earnings press release will be accessible through ... www.anipharmaceuticals.com . Arthur S. Przybyl , ... Arnold , Vice President and Chief Financial Officer, also ...
(Date:7/28/2015)... HACKENSACK, N.J., July 28, 2015  Champions Oncology, Inc. ... solutions and services to personalize the development and use ... the year ended April 30, 2015. Fourth ... increased 32% over the same prior year period result ... than 140 implants Joel Ackerman, Champions Oncology ...
Breaking Medicine Technology:CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11
... 19, 2007 - Amgen,(NASDAQ: AMGN) today ... study", a,randomized, double-blind, placebo-controlled, multicenter Phase ... 600 previously untreated,patients with extensive-stage small-cell ... study demonstrated,no statistically significant difference in ...
... Biomolecular Sciences Conference, THE WOODLANDS, Texas, April ... that data was presented,today highlighting potential therapeutic ... at the Society for Biomolecular,Sciences 13th Annual ... discoveries were made in a collaboration,between Lexicon ...
Cached Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 2Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 3Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 4Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 5
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: